Regulatory Reliance: Thai Program With Singapore Provides Cost-Savings, Earlier Innovations

Thai example of reliance delivers medtech approvals in less than half the time than previously

The 25th IMDRF meeting in March 2024 agreed that regulatory reliance models save resources, encourage innovation, bring devices to the market faster and boost patient access. Singapore and Thailand have operated a model of mutual regulatory reliance for three years. Thailand also recently broached deeper collaboration with Brazil’s Anvisa.

Shutterstock

“Reliance should be used as a process for international cooperation, and we should learn to trust our international partners, because regulators cannot do everything.”

That sentiment is increasingly heard in medtech regulatory circles. In this case, the comment was voiced by Lincoln Tsang, Ropes & Gray’s UK-based European life sciences practice lead, in an interview with Medtech Insight

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Asia

More from Geography